Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer Participates In Community Education Program

This article was originally published in PharmAsia News

Executive Summary

China's Ministry of Health, Community Health Association of China, Bayer Health Care and a local health publisher have kicked off a HOME patient education project. The exercise aims to train some 100,000 community doctors covering 12,000 community health service centers across more than 100 cities, as well as provide public disease and health education programs for patients and population at risk. The total investment of HOME is expected to reach 10 million yuan (1.4 million). MOH's deputy minister points out that setting up a community-based chronic disease management model represents an important breakthrough to solve the issue of limited health care resources and expensive medical care. The latest program seeks to involve more private organizations to build up such community services. (Click here for more - Chinese language)

You may also be interested in...



Warning Letter Roundup & Recap – 1 December 2020

In the only device-related warning letter released by the US FDA this week, Avazo Healthcare was selling two COVID-19 antigen tests without approval, clearance or authorization from the agency.

On-Site Inspections Of US Device Makers Plummet 93% As FDA Scrambles For Virtual Solutions

A sharp decline in the number of in-person facility inspections has forced the FDA to consider creative techniques for remotely evaluating manufacturer compliance during the COVID-19 pandemic. This and other stories topped our list of most-read Medtech Insight articles in November.

EU Health Ministers To Deliberate Over Commission’s Pharma Strategy

A package of health proposals intended to build up the EU’s resilience to health threats while strengthening the competitiveness of Europe’s pharmaceutical industry and ensuring access to affordable drugs takes a major step through the legislative process this week.

UsernamePublicRestriction

Register

LL026487

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel